VIVUS, Inc. (NASDAQ:VVUS) said that it has been experiencing relatively modest growth in Qsymia prescriptions since the launch of the drug in September 2012.
Aquasition Corp. : Approximately 2,600 shares changed hands, a 1,838.4 percent increase over its 65-day average volume. The shares rose $.09 or .9 percent to $9.87.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. To see all exchange delays, please see disclaimer.